Replimune Group (REPL) News Today

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$6.45

-0.52 (-7.46%)

(As of 04/19/2024 ET)

Source

Source	Headline
	Vontobel Holding Ltd. Takes $2.58 Million Position in Replimune Group, Inc. (NASDAQ:REPL) marketbeat.com - April 19 at 5:37 AM
	Head to Head Survey: Replimune Group (NASDAQ:REPL) vs. CG Oncology (NASDAQ:CGON) americanbankingnews.com - April 13 at 1:30 AM
	Vanguard Group Inc. Increases Stake in Replimune Group, Inc. (NASDAQ:REPL) marketbeat.com - April 10 at 4:00 AM
	Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting globenewswire.com - April 7 at 5:00 PM
	Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) globenewswire.com - April 4 at 8:00 AM
	Five things: Downtown building sale, nursing home lawsuit, Fast 50 and the clock is ticking bizjournals.com - March 30 at 9:59 AM
	Replimune appoints new CEO ahead of drug application uk.investing.com - March 29 at 12:50 AM
	Petri Dish: NIH sends BioNTech notice of default; Intellia ends Regeneron deal bizjournals.com - March 28 at 9:48 AM
	Replimune Names Sushil Patel as CEO in Broader Shakeup marketwatch.com - March 26 at 12:12 PM
	Replimune Promotes Sushil Patel To Succeed Philip Astley-Sparke As CEO markets.businessinsider.com - March 26 at 12:12 PM
	Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions globenewswire.com - March 26 at 7:30 AM
	Replimune Group (NASDAQ:REPL) Stock Price Up 5.3% marketbeat.com - March 21 at 4:24 PM
	REPL Apr 2024 10.000 call finance.yahoo.com - March 16 at 12:31 PM
	REPL Mar 2024 10.000 put finance.yahoo.com - March 15 at 4:28 PM
	Replimune to Present at the American Association for Cancer Research Annual Meeting 2024 finance.yahoo.com - March 6 at 7:31 PM
	Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Redmile Group LLC marketbeat.com - March 5 at 8:00 PM
	Replimune to Present at Three Upcoming Investor Conferences finance.yahoo.com - March 5 at 10:04 AM
	FY2024 Earnings Estimate for Replimune Group, Inc. (NASDAQ:REPL) Issued By HC Wainwright marketbeat.com - February 19 at 2:35 AM
	Replimune Group, Inc. (NASDAQ:REPL) Holdings Decreased by Lord Abbett & CO. LLC marketbeat.com - February 16 at 9:48 AM
	Positive Outlook for Replimune Group with Buy Rating and Increased Price Target Amidst Promising RP1 + Opdivo Therapy Trials markets.businessinsider.com - February 15 at 6:48 PM
	Replimune Group, Inc. (NASDAQ:REPL) Expected to Post Q3 2025 Earnings of ($0.71) Per Share marketbeat.com - February 12 at 3:22 AM
	Replimune Group (NASDAQ:REPL) Posts Quarterly Earnings Results, Beats Expectations By $0.12 EPS marketbeat.com - February 9 at 1:39 PM
	Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Replimune Group (REPL) and Phibro Animal Health (PAHC) markets.businessinsider.com - February 9 at 7:41 AM
	Replimune Group Is Worried About This – Should You Be Worried Too? msn.com - February 9 at 7:41 AM
	Replimune Group (NASDAQ:REPL) Shares Up 4% marketbeat.com - February 9 at 2:31 AM
	Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update finance.yahoo.com - February 8 at 11:10 AM
	Replimune Group Inc (REPL) Reports Fiscal Q3 2024 Results and Extends Cash Runway finance.yahoo.com - February 8 at 11:10 AM
	Replimune Group Inc (REPL) investing.com - February 8 at 12:00 AM
	Disc Medicine Taps Ex-Replimune Exec for CFO, Promotes New Operations Chief marketwatch.com - February 7 at 8:58 AM
	Replimune: The Fall Is Justified, As Virus Therapy Fails Again In Cancer seekingalpha.com - January 23 at 1:22 PM
	TD Asset Management Inc Boosts Stake in Replimune Group, Inc. (NASDAQ:REPL) marketbeat.com - January 18 at 5:31 AM
	Replimune Group, Inc. (NASDAQ:REPL) Sees Significant Increase in Short Interest marketbeat.com - January 13 at 1:55 PM
	Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference finance.yahoo.com - December 28 at 9:09 AM
	REPL Feb 2024 30.000 put ca.finance.yahoo.com - December 17 at 8:16 PM
	Balanced Outlook: Replimune’s Setbacks and Potential in Clinical Trials Justify Buy Rating markets.businessinsider.com - December 8 at 8:32 AM
	An Intrinsic Calculation For Replimune Group, Inc. (NASDAQ:REPL) Suggests It's 24% Undervalued finance.yahoo.com - December 7 at 8:51 AM
	Optimistic Buy Rating on Replimune Group Focused on RP1’s Melanoma Treatment Potential and Strategic Realignment markets.businessinsider.com - December 7 at 12:03 AM
	Replimune shares crash as skin cancer candidate fails trial msn.com - December 5 at 11:54 AM
	Replimune shares plunge as skin cancer therapy fails to meet primary clinical-trial goals msn.com - December 5 at 11:54 AM
	Replimune's skin cancer drug fails in mid-stage study reuters.com - December 5 at 11:54 AM
	What's Going On With Cancer-Focused Replimune Stock Today? markets.businessinsider.com - December 5 at 11:54 AM
	Replimune Shares Initial Primary Analysis Results from CERPASS Clinical Trial in Advanced Cutaneous Squamous Cell Carcinoma and Presents New Data from IGNYTE Clinical Trial of RP1 in Anti-PD1 Failed Melanoma and Non-Melanoma Skin Cancers finance.yahoo.com - December 5 at 11:54 AM
	marketbeat.com - December 5 at 7:08 AM
	Replimune Group Stock (NASDAQ:REPL) Dividends: History, Yield and Dates benzinga.com - November 26 at 8:15 PM
	Replimune Group Stock (NASDAQ:REPL), Analyst Ratings, Price Targets, Predictions benzinga.com - November 24 at 10:06 AM
	Analysts’ Opinions Are Mixed on These Healthcare Stocks: Scholar Rock Holding (SRRK), Replimune Group (REPL) and Precision BioSciences (DTIL) markets.businessinsider.com - November 8 at 10:43 PM
	Replimune Presents Updated Data on RP2 in Uveal Melanoma during Plenary Session at the 20th International Congress of the Society for Melanoma Research finance.yahoo.com - November 8 at 12:41 PM
	Replimune Group GAAP EPS of -$0.90 misses by $0.04 msn.com - November 7 at 11:29 AM
	Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update finance.yahoo.com - November 7 at 11:29 AM
	Replimune: Skepticism Is Priced In Ahead Of Long-Awaited CERPASS Data (Rating Upgrade) seekingalpha.com - November 5 at 10:05 AM

Get Replimune Group News Delivered to You Automatically

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

REPL Media Mentions By Week

REPL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

REPL
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

REPL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

REPL Articles
This Week
▼
2

2
▲
REPL Articles
Average Week

Get Replimune Group News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:REPL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Replimune Group (REPL) News Today

REPL Media Mentions By Week

REPL Media Sentiment

REPL News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info